ZYME
$26.91+5.36%
Zymeworks Inc.Stock · HealthcareRussell 2000 · 0.04% of IWMNasdaq Composite · 0.006% of ONEQRussell 3000 · 0.002% of IWVUS Stock Market · 0.002% of VTI
ZYME financial statements
The full income statement, balance sheet, and cash-flow statement for Zymeworks Inc. (ZYME), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 71.0M2024-09 68.9M2024-12 69.6M2025-03 69.7M2025-06 75.2M2025-09 74.8M2025-12 73.7M2026-03 73.0M2026-06 71.0M-0.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 106M+38.9% | 76.3M+0.4% | 76.0M-81.6% | 412M+1446.0% | 26.7M-31.5% | |
| Research & development | 137M+1.8% | 135M-6.3% | 144M-31.1% | 209M+4.4% | 200M+16.7% | |
| Selling, general & administrative | 61.5M+0.0% | 61.5M-12.7% | 70.4M-4.0% | 73.4M+72.4% | 42.6M-22.9% | |
| General & administrative | 61.5M+0.0% | 61.5M-12.7% | 70.4M-4.0% | 73.4M+72.4% | 42.6M-22.9% | |
| Restructuring | — | — | 0.00 | — | — | |
| Amortization of intangibles | 4.06M-9.8% | 4.50M+66.4% | 2.70M+166.2% | 1.01M-63.7% | 2.79M-32.9% | |
| Operating income | -92.5M+32.5% | -137M+0.7% | -138M-205.8% | 131M+160.5% | -216M-15.0% | |
| Other non-operating income | 51.0K+123.4% | -218K-174.9% | 291K+792.9% | -42.0K-135.6% | 118K+437.1% | |
| Pre-tax income | -79.8M+31.6% | -117M+2.2% | -119M-188.2% | 135M+163.7% | -212M-17.9% | |
| Income tax | 1.38M-77.4% | 6.08M+1171.1% | -568K-105.2% | 10.9M+2211.0% | -516K-220.3% | |
| -81.1M+33.9% | -123M-3.4% | -119M-195.4% | 124M+158.7% | -212M-17.3% | ||
| Net income to common | -81.1M+33.9% | -123M-3.4% | -119M-195.4% | 124M+158.7% | -212M-17.3% | |
| -$1.08+33.3% | -$1.62+5.8% | -$1.72-190.5% | $1.90+141.2% | -$4.61-28.8% | ||
| EPS (basic) | -$1.08+33.3% | -$1.62+5.8% | -$1.72-190.1% | $1.91+146.5% | -$4.11-14.8% | |
| Weighted-avg shares (basic) | 75.4M-0.6% | 75.8M+10.1% | 68.9M+5.6% | 65.2M+26.5% | 51.6M+2.3% | |
| Weighted-avg shares (diluted) | 75.4M-0.6% | 75.9M+10.2% | 68.9M+5.5% | 65.2M+25.2% | 52.1M+3.5% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 249M-17.2% | 300M-27.2% | 413M-24.2% | 545M+89.0% | 288M-36.7% | ||
| Cash & equivalents | 41.2M-37.7% | 66.1M-58.0% | 158M-60.7% | 401M+98.6% | 202M-16.6% | |
| Short-term investments | — | — | 217M+137.4% | 91.3M+80.0% | 50.7M-72.5% | |
| Accounts receivable | 4.64M-91.7% | 55.8M+186.6% | 19.5M-41.7% | 33.4M+113.9% | 15.6M+2.1% | |
| Prepaid expenses | 15.3M-18.7% | 18.9M-1.4% | 19.1M+0.3% | 19.1M-4.6% | 20.0M+48.9% | |
| 347M-25.2% | 463M-20.3% | 581M-10.5% | 649M+66.7% | 389M-27.7% | ||
| Property, plant & equipment | 15.5M-12.2% | 17.6M-11.1% | 19.8M-19.7% | 24.7M+8.5% | 22.8M+87.0% | |
| Operating lease right-of-use | 15.7M-5.7% | 16.7M-5.8% | 17.7M-22.8% | 22.9M-15.0% | 27.0M+397.1% | |
| Goodwill | 12.0M+0.0% | 12.0M+0.0% | 12.0M+0.0% | 12.0M+0.0% | 12.0M+0.0% | |
| Intangible assets | 1.35M-70.5% | 4.58M-40.2% | 7.66M-12.6% | 8.76M+128.1% | 3.84M-27.6% | |
| Long-term investments | — | — | 82.1M+9171.8% | 886K+0.0% | 886K-96.6% | |
| Deferred tax assets | 4.71M+7.3% | 4.38M+21.3% | 3.62M+168.8% | 1.34M-56.2% | 3.07M+78.2% | |
| 42.3M-52.1% | 88.3M+58.3% | 55.8M-41.7% | 95.6M+33.1% | 71.9M-16.1% | ||
| Accounts payable | 4.40M+12.8% | 3.90M-37.2% | 6.21M-21.0% | 7.86M+52.0% | 5.17M-17.1% | |
| Accrued liabilities | 36.3M-39.3% | 59.8M+30.1% | 46.0M-47.4% | 87.5M+39.3% | 62.8M+43.8% | |
| Deferred revenue | 2.42M-90.6% | 25.6M+591.8% | 3.70M+57.2% | 2.35M | 0.00 | |
| Current lease liability | 3.47M+26.7% | 2.74M-35.7% | 4.26M+28.3% | 3.32M+153.6% | 1.31M-51.7% | |
| Other current liabilities | — | — | — | — | 22.0K+29.4% | |
| Finance lease liability (current) | 0.00-100.0% | 28.0K-6.7% | 30.0K+87.5% | 16.0K-27.3% | 22.0K+29.4% | |
| 78.0M-37.2% | 124M+7.1% | 116M-25.5% | 156M+11.2% | 140M+9.0% | ||
| Deferred revenue (non-current) | 14.6M-0.0% | 14.6M-55.7% | 32.9M+7.7% | 30.6M-7.1% | 32.9M+0.0% | |
| Non-current lease liability | 14.8M-6.0% | 15.7M-29.6% | 22.4M-9.3% | 24.7M-20.2% | 30.9M+432.1% | |
| Operating lease liability (total) | 18.3M-1.1% | 18.5M-30.6% | 26.6M-4.9% | 28.0M-13.2% | 32.2M+278.2% | |
| Finance lease liability (total) | 0.00-100.0% | 56.0K-54.1% | 122K-12.9% | 140K+14.8% | 122K-12.2% | |
| Finance lease liability | 0.00-100.0% | 28.0K-69.6% | 92.0K-25.8% | 124K+24.0% | 100K-18.0% | |
| Deferred tax liabilities | 6.03M+26.6% | 4.76M+44.3% | 3.30M+84.6% | 1.79M+13.7% | 1.57M+33.5% | |
| Other non-current liabilities | 278K-69.9% | 923K-45.7% | 1.70M-45.1% | 3.10M+12.8% | 2.75M-3.8% | |
| 269M-20.7% | 339M-27.1% | 465M-5.7% | 493M+97.9% | 249M-39.2% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 1.11B+8.8% | 1.02B+1.8% | 997M+12.5% | 886M+19.6% | 741M+2.3% | |
| Additional paid-in capital | 115M-24.7% | 152M+7.0% | 142M-6.2% | 152M-23.3% | 198M+20.8% | |
| Retained earnings | -953M-14.8% | -830M-22.6% | -677M-21.2% | -559M+18.2% | -683M-45.0% | |
| Accumulated other comprehensive income | -6.08M+12.6% | -6.95M-5.3% | -6.60M+0.8% | -6.66M+0.0% | -6.66M+0.0% | |
| Total liabilities & equity | 347M-25.2% | 463M-20.3% | 581M-10.5% | 649M+66.7% | 389M-27.7% | |
| Common shares issued | 74.6M+8.2% | 69.0M-1.6% | 70.1M+11.2% | 63.1M+35.2% | 46.6M+1.3% | |
| Common shares outstanding | 74.6M+8.2% | 69.0M-1.6% | 70.1M+11.2% | 63.1M+35.2% | 46.6M+1.3% | |
| Shares outstanding (cover) | 73.7M+6.0% | 69.6M-1.4% | 70.6M+10.2% | 64.0M+10.9% | 57.7M+25.1% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -33.0M+70.0% | -110M+7.0% | -118M-182.1% | 144M+174.9% | -192M-27.1% | ||
| Depreciation & amortization | 7.72M-11.0% | 8.68M-14.6% | 10.2M+40.5% | 7.24M+93.5% | 3.74M+11.4% | |
| Intangible amortization | 4.06M-9.8% | 4.50M+66.4% | 2.70M+166.2% | 1.01M-63.7% | 2.79M-32.9% | |
| Share-based compensation | 28.0M+57.6% | 17.8M+119.6% | 8.10M+101.8% | 4.01M-62.7% | 10.8M-63.1% | |
| Deferred income taxes | 945K+36.8% | 691K+191.3% | -757K-139.0% | 1.94M+303.6% | -953K-795.6% | |
| Change in receivables | -51.2M-240.8% | 36.4M+361.2% | -13.9M-179.5% | 17.5M+6482.3% | 266K-98.0% | |
| 26.7M-31.2% | 38.8M+118.7% | -207M-284.9% | -53.8M-137.2% | 145M+432.9% | ||
| Capital expenditure | 1.52M-23.6% | 1.99M-19.5% | 2.47M-69.6% | 8.15M-34.3% | 12.4M+187.8% | |
| Free cash flow | -34.5M+69.2% | -112M+7.2% | -121M-188.8% | 136M+166.4% | -205M-31.6% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -18.6M+9.2% | -20.4M-125.0% | 81.9M-24.6% | 109M+1255.4% | 8.01M-97.4% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 26.2M-75.6% | 108M | 0.00-100.0% | |
| Common stock repurchased | 41.7M+38.7% | 30.1M | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | -45.0K-115.7% | 286K-19.2% | 354K+74.4% | 203K+162.5% | -325K+40.9% | |
| Net change in cash | -24.9M+72.7% | -91.5M+62.4% | -243M-222.3% | 199M+595.5% | -40.2M-135.4% | |
| Income taxes paid | 1.35M-57.5% | 3.18M+1826.7% | 165K-98.4% | 10.0M | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.94B+90.6% | 1.02B+40.0% | 727M+46.9% | 495M-47.7% | 946M-56.6% | |
| P/E | — | — | 3.5× | — | — | |
| P/S | 18.3×+37.3% | 13.3×+747.2% | 1.6×-90.5% | 16.6×-53.2% | 35.5×-36.6% | |
| P/B | 7.2×+140.5% | 3.0×+75.4% | 1.7×-37.8% | 2.8×-27.5% | 3.8×-28.6% | |
| P/FCF | — | — | 3.8× | — | — | |
| Earnings yield | — | — | 28.2% | — | — | |
| FCF yield | — | — | 26.5% | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
One company, more than one SEC registrant: these statements were filed by Zymeworks BC Inc. until Oct 13, 2022 and by Zymeworks Inc. since.
About this data
Source: ZYME’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ZYME filings on SEC EDGAR → Not investment advice.